Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News | Blood Testing

September 18, 2019 โ€” Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high ...

Home September 18, 2019
Home
News

September 17, 2019 โ€” Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...

Home September 17, 2019
Home
News | Heart Failure

September 12, 2019 โ€” Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...

Home September 12, 2019
Home
News | Heart Valve Technology

September 11, 2019 โ€” Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...

Home September 11, 2019
Home
News | Heart Failure

September 11, 2019 โ€” The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...

Home September 11, 2019
Home
News | Heart Failure

September 11, 2019 โ€” The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...

Home September 11, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

September 10,2019 โ€” The combination of ticagrelor and aspirin reduces ischemic events compared with aspirin alone in ...

Home September 10, 2019
Home
News | Cath Lab

September 10, 2019 โ€” An international randomized trial has shown that complete revascularization reduces major ...

Home September 10, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

September 9, 2019 โ€” Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary ...

Home September 09, 2019
Home
News | Heart Failure

September 9, 2019 โ€” AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...

Home September 09, 2019
Home
ESC President Barbara Casadei, M.D., DPhil, FRCP, FESC, a British Heart Foundation Professor and an honorary consultant cardiologist at the John Radcliffe Hospital in Oxford, speaks at a press conference at the 2019 ESC Congress. #ESC19 #ESC2019
Feature | ESC

September 9, 2019 โ€” More than 33,000 health professionals gathered over five days to attend the 2019 European Society of ...

Home September 09, 2019
Home
News | Heart Failure

September 9, 2019 โ€” The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...

Home September 09, 2019
Home
News | Stents Drug Eluting

September 5, 2019 โ€” Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...

Home September 05, 2019
Home
News | Heart Failure

September 4, 2019 โ€“ Novartis announced results from two new clinical trials evaluating improvement in heart structure ...

Home September 04, 2019
Home
News | Cardiovascular Ultrasound

September 4, 2019 โ€” Final data from the World Alliance Societies of Echocardiography (WASE) Normal Values Study was ...

Home September 04, 2019
Home
Subscribe Now